Magnus S.
- Country
- Sweden
- Department
- Childhood cancer centre (ward 322)
Research Overview
- Evaluation of Hyperfractionated-Accelerated Radiotherapy and High-Dose Thiotepa Therapy in High-Risk Medulloblastoma Patients Aged Over 3 Years
- Evaluation of Carboplatin and Chemotherapeutic Regimen in Pediatric Patients with Standard-Risk and High-Risk Medulloblastoma: A Multinational Prospective Study
- Phase II Evaluation of Metronomic and Targeted Anti-Angiogenic Therapy with Bevacizumab in Pediatric Recurrent/Progressive Medulloblastoma, Ependymoma, and ATRT
Data & Insights
Has run more than one trial at 97 of 162 partner sites.
Specializations
Pediatric Brain Tumors
The investigator specializes in treating complex pediatric brain tumors, with particular focus on medulloblastoma and atypical teratoid/rhabdoid tumors (ATRT). Their research encompasses both standard-risk and high-risk disease variants.
- Medulloblastoma Subtypes
- ATRT Treatment Strategies
- Molecular Risk Stratification
Clinical interests include specific molecular subgroups such as sonic hedgehog (SHH) and non-WNT/non-SHH variants.
Treatment Innovation
The investigator explores innovative therapeutic approaches including metronomic anti-angiogenic treatment and hyperfractionated-accelerated radiotherapy (HART) for brain tumors.
- Anti-angiogenic Strategies
- Advanced Radiotherapy Techniques
- High-dose Therapy Protocols
Research focus includes evaluation of reduced-intensity chemotherapy protocols and novel consolidation approaches.
Age-Specific Protocols
The investigator develops specialized treatment protocols for different age groups, from infants to adolescents, with particular attention to age-adapted therapeutic strategies.
- Infant Treatment Protocols
- Childhood Brain Tumor Therapy
- Adolescent Treatment Approaches
Clinical work includes customized protocols for patients aged under 12 months through to those over 36 months.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.